Patients with acute myelogenous leukemia (AML) should not use Fildena 50. This is a Class II Biologic Response Modifier drug. This drug has been associated with an increased risk of bone marrow cancer, cervical cancer, kidney cancer, and gastrointestinal cancers in postmenopausal women. The mechanism for the increased risk includes the ability of PDE-5-3 alpha to interact with a number of immune cell receptors. This is the reason that PML was added to the USAN list of controlled substances. This controlled substance is believed to increase the risk of PML by affecting the function of the PDE-5-alpha receptor.
Animal studies performed on animals do not reflect human usage. It is not known if the drug affects humans when given the doses normally used by human clinical trials. It has not been found to cause teratogenic effects, sexual side effects, or allergic reactions. Some patients using Fildena 50mg viagra have reported nausea, vomiting, diarrhea, and stomach cramps. Reported cases of hypoglycemia include a man who was using Fildena 50mg when he became dehydrated after exercising.
Patients with known cardiac disease should not take Fildena 50mg. There are several possible reasons for this. The levels of cocaine and its metabolite, benzyl peroxide, cause a lowering of blood pressure in people with known cardiac disease. The drug may also lower the antioxidant enzymes and glutathione, which play an important role in maintaining the antioxidant status of blood cells.
There are some drug interactions between Fildena and cimetidine that have been reported in patients with ulcerative colitis. This condition can occur because of impaired immunity. Doctors treating patients with ulcerative colitis with Fildena 50mg may sometimes notice an improvement in the condition after beginning a course of this medication. However, the improvement usually fades as the ulcerative colitis progresses. The drug may also cause a mild increase in blood sugar levels.